Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Deafness
ADR ID BADD_A01156
ADR Hierarchy
04      Ear and labyrinth disorders
04.02      Hearing disorders
04.02.01      Hearing losses
04.02.01.001      Deafness
Description A general term for the complete loss of the ability to hear from both ears. [MeSH]
MedDRA Code 10011878
MeSH ID D003638; D034381
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Deaf | Deafness | Deafness NOS | Hearing loss | High frequency deafness | Low frequency deafness | No hearing | Other specified forms of deafness | Other specified forms of hearing loss | Unspecified deafness | Unspecified hearing loss | Deafness (NOS) | Deafness total | Surdity | Deafness toxic | Complete hearing loss | Cophosis | Deafness, Acquired | Acquired Deafness | Hearing Loss, Extreme | Extreme Hearing Loss | Deaf Mutism | Deaf-Mutism | Hearing Loss, Complete | Complete Hearing Loss | Bilateral Deafness | Deafness, Bilateral | Prelingual Deafness | Deafness, Prelingual
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01137Imatinib mesylate--
BADD_D01156Indomethacin--
BADD_D01166Interferon alfa-2a--
BADD_D01167Interferon alfa-2b--
BADD_D01168Interferon alfacon-1--
BADD_D01178Iodixanol--
BADD_D01181Iopamidol--
BADD_D01194Irbesartan0.000126%
BADD_D01197Iron--
BADD_D01213Isotretinoin--
BADD_D01217Itraconazole--
BADD_D01220Ivacaftor-
BADD_D01226Kanamycin--
BADD_D01227Kanamycin sulfate--
BADD_D01231Ketoprofen--
BADD_D01232Ketorolac--
BADD_D01233Ketorolac tromethamine--
BADD_D01238Lacosamide0.001463%
BADD_D01241Lamisil--
BADD_D01242Lamivudine--
BADD_D01243Lamotrigine--
BADD_D01245Lansoprazole0.000149%
BADD_D01253Lenalidomide--
BADD_D01257Letrozole0.000922%
BADD_D01260Leuprolide acetate--
BADD_D01275Levofloxacin--
BADD_D01285Levothyroxine0.000027%
BADD_D01287Lidocaine--
BADD_D01317Loratadine0.000048%
BADD_D01318Lorazepam0.000046%
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 13 Pages